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Abstract
Background: Misfolded proteins are generally recognised by cellular quality control machinery, which typically results in
their ubiquitination and degradation. For soluble cytoplasmic proteins, degradation is mediated by the proteasome.
Membrane proteins that fail to fold correctly are subject to ER associated degradation (ERAD), which involves their
extraction from the membrane and subsequent proteasome-dependent destruction. Proteins with abnormal transmem-
brane domains can also be recognised in the Golgi or endosomal system and targeted for destruction in the vacuole/
lysosome. It is much less clear what happens to membrane proteins that reach their destination, such as the cell surface, and
then suffer damage.
Methodology/Principal Findings: We have tested the ability of yeast cells to degrade membrane proteins to which
temperature-sensitive cytoplasmic alleles of the Ura3 protein or of phage lambda repressor have been fused. In soluble
form, these proteins are rapidly degraded upon temperature shift, in part due to the action of the Doa10 and San1 ubiquitin
ligases and the proteasome. When tethered to the ER protein Use1, they are also degraded. However, when tethered to a
plasma membrane protein such as Sso1 they escape degradation, either in the vacuole or by the proteasome.
Conclusions/Significance: Membrane proteins with a misfolded cytoplasmic domain appear not to be efficiently
recognised and degraded once they have escaped the ER, even though their defective domains are exposed to the
cytoplasm and potentially to cytoplasmic quality controls. Membrane tethering may provide a way to reduce degradation of
unstable proteins.
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Introduction
Degradation of misfolded proteins is a key mechanism for
cellular maintenance and a major use of the ubiquitin modification
system. Misfolded cytoplasmic proteins undergo polyubiquitina-
tion with K48-linked chains; these are then recognised by the
proteasome and the ubiquitinated proteins degraded [1–3].
Newly-synthesised membrane and secretory proteins that fail to
fold are recognised in the endoplasmic reticulum, ejected into the
cytoplasm and ubiquitinated, before similarly undergoing protea-
somal degradation in a process termed ER-associated degradation
(ERAD) [4–6]. Membrane proteins that reach the Golgi or plasma
membrane can also be degraded when necessary; they undergo
subsequent addition of single ubiquitins, or K63-linked chains,
which direct them into multivesicular bodies for degradation in the
lysosome or vacuole [7–10].
The key common requirement is that misfolded proteins, in
various locations, are recognised as such by an appropriate
ubiquitin ligase. In yeast, several have been identified. For ER-
associated degradation the membrane-associated RING domain
E3 ligases Hrd1 and Doa10 are the prime candidates [11–13].
Surprisingly, Doa10 is also implicated in the degradation of some
soluble proteins [11,14,15]. The nuclear RING domain protein
San1 is involved in the destruction of several temperature-sensitive
nuclear proteins [16]. Membrane proteins that escape the ER can
be recognised by the RING protein Tul1 [17], or by the adaptor
Bsd2, which recruits the HECT domain ligase Rsp5 [18]. Both
these proteins recognise primarily polar transmembrane regions,
as would be exposed by misfolding of the membrane-spanning
portion of a polytopic protein, and they serve to target proteins to
the vacuole. Both appear to function in the Golgi and endosomes.
Despite these findings, there remains considerable uncertainty
over the systems responsible for degradation of abnormal proteins,
partly because of redundancy. For example, soluble proteins may
aggregate and undergo autophagy as well as being degraded by
the proteasome [19], and there may well be multiple enzymes
capable of ubiquitinating any given protein.
We have sought to understand the full range of quality control
of membrane proteins. Though most mistakes occur during the
initial folding process, and thus can be detected at the level of the
ER or Golgi, there is at least the potential for damage to proteins
after they arrive at their destination. Are plasma membrane
proteins constantly monitored for damage, and if so, how are they
disposed of? If, for example, the cytoplasmic domain of a plasma
membrane protein is damaged, will it be recognised by the
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address this, we have fused temperature sensitive soluble proteins
to membrane anchors and investigated their degradation after a
temperature shift. Surprisingly, though these proteins are
degraded when soluble or attached to the ER, once delivered
to the cell surface or vacuolar membrane they are much more
stable. It appears that such proteins are quite well tolerated by
cells, and there is no quality control system designed to destroy
them rapidly.
Results
Degradation of cytoplasmic Ura3 fusion proteins
Our strategy was first to identify soluble proteins whose
metabolic stability could be controlled by a temperature shift,
then attach these to a membrane anchor. Initially, we mutagenised
a myc-tagged version of Ura3 and isolated temperature-sensitive
mutants by their ability to grow at 37uC on 5-fluoro-orotic acid,
which kills cells with active Ura3. These mutants were then
screened for Ura3 degradation during a cycloheximide chase. Two
mutants were obtained with non-conservative changes in distinct
regions of the protein: Ura3-2 had Pro144 changed to Leu, and
Ura3-3 had Asp243 changed to Gly, as well as the conservative
mutation of Lys176 to Arg. The structural consequences of the two
mutations are expected to be distinct [20]. Asp243 is at the start of
a C-terminal helix of the Ura3 monomer, and its conversion to
Gly might destabilise this helix. Pro144 on the other hand is in a
turn on the opposite side of the molecule. Figure 1A shows that
both these proteins persisted during a cycloheximide chase at
25uC, but after shifting to 37u they were rapidly degraded. In both
cases this degradation was dramatically slowed in the temperature
sensitive proteasome mutant cim3-1 (Figure 1B), suggesting that
they were subject to proteasomal degradation, presumably
ubiquitin-mediated.
Ura3 variants with random peptides appended to them have
been shown to be substrates for the Doa10 ubiquitin ligase [21].
Our ts alleles had a longer lifetime in a doa10 deletion mutant, but
the fact that degradation could still be observed implies that
Doa10 is not the only ligase contributing to their fate (Figure 1A).
To test whether the metabolic instability of the Ura3 mutants
could be extended to a fusion protein, we tagged them with GFP.
The GFP fusions were degraded in a temperature-sensitive
manner, and this was blocked by the ts proteasome mutant
cim3-1 (shown for Ura3-3(GFP) in Figure 1D), although not
significantly in a doa10 mutant (Figure 1C, D). However, we found
that their degradation was substantially reduced by mutation of
San1, a nuclear RING finger ubiquitin ligase that has been
implicated in the turnover of ts proteins in the nucleus [16]
(Figure 1C, D). Though Ura3 is primarily a cytoplasmic protein, it
appears that there is sufficient contact between San1 and Ura3-
GFP to allow ubiquitination and subsequent proteasomal
degradation of the fusion protein. The enhanced dependence on
San1 shown by the GFP fusions may relate to a weak affinity of
GFP for the nucleus. Indeed, microscopic examination showed
that Ura3-GFP was present throughout the cytoplasm and
nucleus, though it was excluded from vacuoles (data not shown;
see also below).
Doa10 is an ER membrane protein, and may share some
functions with Hrd1, the other major ER ubiquitin ligase.
However, Ura3-3(GFP) was efficiently degraded in a hrd1 deletion
mutant, and as efficiently in a hrd1 doa10 double mutant as in the
doa10 single mutant (Figure 1D). It appears therefore that this
protein is not a substrate for Hrd1.
Fusion of temperature-sensitive proteins to SNAREs
Having established that the ts alleles of Ura3 could induce
degradation of attached proteins, we fused the mutant Ura3-GFP
chimeras to the plasma membrane SNARE protein Sso1.
Fluorescence microscopy confirmed that the bulk of the Ura3-
2(GFP-Sso1) construct was indeed at the plasma membrane
Figure 1. Degradation of temperature-sensitive Ura3 alleles. A.
Cells expressing myc-tagged Ura3 proteins were treated with cyclo-
heximide and incubated at 25 or 37uC for the times indicated. Total
protein samples were immunoblotted, with phosphoglycerate kinase
(PGK) serving as an internal control. Molecular weights (kDa) of the
proteins are indicated on the left of the blot B. As A, but with wild-type
and cim3-1 (ts proteasome mutant) cells. Note that for this test cells
were incubated at high temperature for one hour before cycloheximide
addition (at time 0). C. GFP-tagged Ura3-2 in wild-type and the
indicated mutant cells. D. GFP-tagged Ura3-3 in the indicated stains.
doi:10.1371/journal.pone.0005038.g001
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ature-sensitive for growth in the absence of uracil (Figure 2B).
Strikingly, however, temperature shift did not induce degradation
of the resultant fusion proteins (Figure 2C).
We extended these studies by fusing Ura3-2(GFP) to three more
SNARES: Snc1, also found mainly on the plasma membrane;
Vam3, found on the vacuolar membrane; and Use1, an ER
resident SNARE. The Snc1 and Vam3 fusions also avoided
degradation after temperature shift (Figure 2D). In contrast,
although GFP-Use1 itself was stable, addition of the Ura3-2
protein resulted in rapid degradation at 37uC (Figure 2E). Thus, a
SNARE fusion can be degraded, but apparently only if it is in the
ER where quality control of membrane proteins typically occurs.
When located on the plasma membrane the fusion proteins escape
proteasome-mediated degradation, even though they are exposed
to the cytoplasm. Furthermore, though some protein could be seen
on the vacuolar membrane, even after prolonged incubation at
37u there was no sign of GFP accumulation within the vacuole
(Figure 2A). Nor could we detect free GFP by immunoblotting (not
shown); this is a characteristic product of the vacuolar degradation
of fusion proteins since GFP itself is protease resistant.
Membrane attachment affects degradation of a ts
lambda repressor
As an independent test of this phenomenon, we used a mutant
(L57A, A66T) of the N-terminal 92 amino-acid region of the
bacteriophage lambda repressor. The A66T mutation is present
in the c1857 temperature-sensitive repressor [22], and the L57A
mutation has been shown to induce physical unfolding at
temperatures above 20uC [23]. Unlike the Ura3 mutants, this
protein is monomeric and it should also unfold at normal yeast
growth temperatures, thus avoiding any potential complications
due to heat stress of the cells. A GFP fusion to the mutant
repressor was stable at 16u, but was degraded at 30u in wild type
cells. It was not degraded in the cim3-1 proteasome mutant, but
was degraded in cells lacking Doa10, San1 or both (Figure 3).
Thus, it is likely to be a substrate for one or more ubiquitin
ligases that do not recognise the Ura3 mutants, or possibly for
the proteasome itself.
Despite these differences between the properties of the lambda
repressor and Ura3 mutants, fusion of the repressor-GFP
construct to Sso1 inhibited its degradation, just as with the
Ura3 mutants (Figure 3). However, equivalent fusions to the ER
SNARE Use1 were degraded, indicating that they were capable
of becoming substrates for the ER-associated degradation
machinery (Figure 3).
Figure 2. Fusion of Ura3 mutants to membrane proteins. A.
Fluorescence image of cells expressing Ura3-2 fused to GFP-Sso1, after
incubation for two hours at 37uC. B. Growth curves of wild-type cells
and those expressing soluble Ura3-2 or the same protein fused to GFP-
Sso1. Mean and standard deviation of triplicate samples are shown.
Note optical density is log scale. Cells were shifted to 37uC at time zero
but there is a lag before growth slows, presumably due to pools of
uracil. The membrane tethered form remained ts, though with a slightly
longer lag. Similar results were obtained with Ura3-3. C. Cycloheximide
chase of the Sso1 fusions at 37uC. D. Cycloheximide chase of equivalent
fusions of Ura3-2 to Snc1 and Vam3. E. Cycloheximide chase of GFP-
Use1 with and without Ura3-2 attached to it. Numbers to the left of the
blots indicate the actual molecular weights of the proteins (kDa). SNARE
fusions typically migrate more slowly than standard molecular weight
markers, appearing about 10 kDa larger than they are.
doi:10.1371/journal.pone.0005038.g002
Figure 3. Degradation of a temperature-sensitive lambda
repressor allele is affected by membrane attachment. The
mutant repressor was fused to soluble GFP or to GFP-Sso1 (Sso1 fusion)
or GFP-Use1 (Use1 fusion) and cyclohemimide chases performed with
the indicated strains and temperatures. The PGK control was only
probed in the top two panels, due to its poor separation from the
fusion protein.
doi:10.1371/journal.pone.0005038.g003
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It has been reported that some abnormal proteins, such as a
temperature sensitive mutant of Ubc9, accumulate in discrete
punctae prior to degradation [19]. If this is a necessary step, it
could explain why membrane-tethered proteins, which presum-
ably are restricted in their movement, suffer a different fate from
soluble ones. We therefore investigated the distribution of our
soluble GFP chimeras following temperature shift.
The Ura3-2(GFP) construct was quite uniformly distributed at
25u, with only an occasional bright spot (Figure 4A). However,
within 30 minutes of shifting the temperature to 37u in at least 80–
90% of the cells the majority of the protein was in large fluorescent
spots, consistent with aggregation. Surprisingly, however, this
aggregation was almost completely prevented by the addition of
cycloheximide prior to the temperature shift (Figure 4A). This
dramatic difference led us to investigate whether the degradation
of the protein was affected by cycloheximide, which is used in our
standard assay. We used the glucose-repressible GAL1 promoter to
drive synthesis of Ura3-2(GFP) at low temperature, added glucose
to repress transcription for four hours, then subjected the cells to
high temperature. Figure 4B shows that the fusion protein was
degraded just as it was in the presence of cycloheximide.
We also examined the GFP-tagged lambda repressor mutant,
and found that it had a dispersed distribution with a few small
bright dots, whether the cells were kept at 16u or had been shifted
to 30u for one hour (Figure 4C). Taken together, these results
indicate that the distribution of our mutant proteins does not
correlate with their metabolic stability. There is thus little reason
to believe that substantial aggregation or specific localisation is an
obligatory or regulating step in their destruction. We cannot, of
course, rule out the possibility that small or transient clusters are a
necessary intermediate.
Discussion
Our goal was to test how yeast cells deal with membrane
proteins whose cytoplasmic domain becomes damaged. Using two
temperature-sensitive mutants of Ura3 and one of the lambda
repressor, all of which are degraded at high temperature when in
soluble form, we reached the surprising conclusion that plasma or
vacuolar membrane proteins bearing misfolded domains are not
rapidly degraded either by the proteasome system or the vacuolar
system. However, when attached to the ER, the domains do
trigger rapid proteasomal destruction. It seems that cells rely on
the ERAD system to catch misfolded proteins before they escape
to other organelles, and have no special way to remove them if
they misfold after reaching their destination.
It seems likely that the most common problem with membrane
proteins is a failure to fold initially, in which case they are subject
to ERAD. It may be that misfolding at a later stage is uncommon,
and since the proteins we have studied do not aggregate when
membrane-tethered, they may not be particularly harmful to the
cell. Perhaps, therefore, there is no need for machinery to remove
them.
What is curious, however, is that the proteins are not degraded
even though they are exposed to the cytosol, and when free to
move in the cytosol are good substrates for degradation. We
considered several possible explanations for this. One is that
some form of aggregation or localisation is necessary for
degradation, but is prevented by membrane tethering. However,
we could find little evidence that degradation of the soluble
forms of the proteins was linked to their localisation. Second, the
membrane proteins may be inaccessible to the ubiquitin ligases
that recognise unfolded proteins. This is a plausible explanation,
since the Ura3 mutants required either Doa10, an ER
membrane protein, or San1, a nuclear protein, for their
degradation. These ligases do seem to be major contributors to
quality control, since several nuclear temperature-sensitive
proteins are San1 substrates [16], and in a previous study
peptide fusions to Ura3 that were selected for their instability all
turned out to be Doa10 substrates [21]. Nevertheless, the lambda
repressor mutant was degraded even in the absence of Doa10
and San1, yet was still rescued by membrane tethering. Thus,
there must be at least one other enzyme involved in the turnover
of unfolded proteins, and it too is evidently unable to mediate the
degradation of plasma membrane proteins.
A third possibility is that the location next to a membrane is a
protected environment, from which ubiquitin ligases and/or
proteasomes are excluded, except for the ER where specific
targeting mechanisms overcome this. It is notable that specific
machinery is thought to recruit proteasomes to the ER membrane
as well as extract membrane proteins [6], and such components
may be absent from the plasma membrane. Interestingly,
however, at least one protein of the outer mitochondrial
Figure 4. Aggregation does not correlate with degradation. A.
GFP-tagged Ura3-2 was imaged in cells incubated at 25uC or 30 mins
after a shift to 37uC, in the presence or absence of cycloheximide. B.
GFP-tagged Ura3-2 was expressed from the GAL promoter, then
expression repressed by growth in glucose prior to temperature shift,
in the absence of cycloheximide. Degradation was normal even though
the aggregation state of the protein was different from that in
cycloheximide. C. GFP-tagged lambda repressor in cells gown at 16uC,
or one hour after shifting to 30uC. The images have been approximately
normalised for intensity.
doi:10.1371/journal.pone.0005038.g004
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proteasome system [24], so the ER may not be unique in this
respect.
It is also possible that quality control at the plasma membrane is
actively countered, for example by localised chaperones or
deubiquitinating enzymes. Deubiquitination has in fact been
proposed to explain why the Pma1-7 mutant of the plasma
membrane ATPase, which is normally ubiquitinated and routed
from Golgi to vacuole, appears stable if allowed to reach the
plasma membrane [25]. Efficient re-folding seems unlikely, given
that Ura3 activity remains temperature sensitive when tethered to
the membrane. We have subsequently directly screened mutagen-
ised versions of tethered Ura3 and obtained additional alleles that
were very tightly temperature-restricted for growth without uracil,
but again none of these were degraded at high temperature.
It may be that the unfolded proteins are ubiquitinated on the
plasma membrane, but escape degradation simply because they
cannot be extracted from this membrane and are poor substrates
for endocytosis. It could be, for example, that K48-linked
ubiquitin chains are not well recognised by the endocytic
machinery and instead are removed by deubiquitinating enzymes.
If so, one might expect ubiquinated forms of the ts proteins to
appear after temperature shift. We did in fact detect ubiquitinated
forms of the ts Ura3(GFP-Sso1) constructs. However, the
appearance of these forms was not reproducibly temperature-
dependent, and they represented a very minor fraction of the
protein. We were therefore unable to rule out the alternative
possibility that they comprised a minor fraction of constitutively
misfolded, and thus non-fluorescent, protein that remains in the
ER and undergoes ERAD. The question of ubiquitination at the
plasma membrane is thus still open.
It remains to be seen whether the yeast results can be
generalised to other species, but there are reasons to be cautious.
For example, misfolded proteins are usually recognised by
chaperone proteins, and in animal cells persistently misfolded
proteins are thought to become substrates for a soluble chaperone-
associated ubiquitin ligase termed CHIP [26]. However, yeast
lacks a CHIP homologue, and thus such a mechanism may not
apply.
It is possible, of course, that machinery exists in yeast to remove
plasma membrane proteins with cytoplasmic domains that are
more extensively damaged than is the case for the three ts proteins
we have used, for example if they undergo extensive aggregation.
Indeed, the temperature sensitive Pma1-10 protein has been
reported to be degraded after arrival at the cell surface [27].
However, this protein may undergo misfolding of its transmem-
brane portion, which would allow it to be recognised by quality
control components that monitor structure within the lipid bilayer.
In this work we have focussed exclusively on independently-folded
cytoplasmic domains. Our conclusion is that quality control for
such domains either does not exist, or is much less stringent and
effective than that for soluble proteins. One implication is that
membrane tethering is a potential strategy for preventing
degradation of unstable proteins.
Materials and Methods
Yeast strains
Yeast strains unless otherwise stated were from the Open
Biosystems knockout collection in a BY4742 (MATa uraD0 leu2D0
his3D1 lys2D0) background. The doa10 san1 double mutant was
made by homologous recombination with a replacement of the
DOA10 open reading frame in the BY4742 san1 knockout strain by
a PCR product encoding the Schizosaccharomyces pombe HIS5 gene.
The doa10 hrd1 double mutant was made similarly. The cim3-1 and
corresponding wild type strain [28] were obtained from Carl
Mann (SBIGeM CEA/Saclay France).
Plasmids
PmUra414 was made by insertion of a c-myc tagged PCR
product from the URA3 gene into a version of pRS414 bearing the
TPI1 promoter. The ura3 mutants were made by error-prone PCR
mutagenesis [29]. The mutated PCR products were co-trans-
formed into SEY6210 (MATa ura3-52 leu2-3, -112 his3-D200 trp1-
D901 lys2-801 suc2-D9) together with Nco1-Bpu101 cut
pmUra414 and selected on plates lacking tryptophan. A pool of
colonies was then plated onto 5-fluoroorotic acid plates at either
25uCo r3 7 uC. Colonies from these plates were streaked out and
further tested for temperature sensitive growth on plates lacking
uracil. Rescued plasmids were sequenced.
In-frame GFP fusions were made between downstream EcoR1
and BamH1 sites. The SSO1 fusion was made by replacement of
the GFP with a GFP-SSO1 fusion [30]. Fusions were similarly
made to the N-termini of SNC1 and VAM3. USE1 was cloned by
PCR into a TPI1-promoter-GFP containing version of pRS416
and the GFP-USE1 fusion used to replace GFP in the URA3 fusion
constructs.
The region encoding the first 92 amino acids from the c1857
bacteriophage lambda repressor was cloned by PCR and
subsequently mutated by PCR to introduce a L57A change [23].
This fragment was subsequently used to replace the URA3 moiety
in the GFP fusion constructs. Galactose-inducible constructs were
made by placing the fusion constructs in a version of YCpLac33
carrying the GAL1/10 promoter fragment. Sequences of all PCR
generated constructs were verified by DNA sequencing.
Cycloheximide chase experiments
Cells were grown into early log phase and after addition of
cycloheximide (to 500 mg/ml) were shaken at the temperatures
shown, and samples taken at the indicated times. These were spun
down and stored on dry ice before being subjected to alkaline lysis
and solublisation as described by [31]. Samples were run on
PAGE and western blots probed with anti-GFP (Roche Diagnos-
tics) and anti PGK (Molecular Probes). In experiments using the
cim3-1 strain, cells were preincubated for 1 hour at 37uC prior to
the addition of cycloheximide. For the galactose shutoff experi-
ments cells were transferred from medium containing 2%
galactose and raffinose into medium containing 2% glucose for
4 hours before temperature shift.
Imaging
Live cell imaging was performed on concanavalin-A coated
slides using a Zeiss LSM510. Images were adjusted for contrast
and brightness, and in some cases, they were blurred to filter noise,
by using Adobe Photoshop (Adobe Systems, Mountain View, CA).
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